Zusammenfassung
Die Lunge steht in der Metastasenentwicklung vor dem Skelett und nach der Leber an 2. Stelle (Willis 1973). Die verschiedenen Tumorerkrankungen entwikkeln unterschiedlich häufig in 20–50% der Fälle Lungenmetastasen. Die Tumor- dissemination ins Lungenparenchym erfolgt vorrangig hämatogen und/oder lymphogen (Liotta et al. 1976). 80–90% der Metastasen siedeln sich in den peripheren Lungenabschnitten oder subpleural an (Crow et al. 1981; Schölten u. Kreel 1977). Solitäre Infiltrate sind seltener als multiple Lungenmetastasen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Azar HA, Espinoza CG, Richman AV (1982) „Undifferentiated“large cell malignancies: An ultrastructural and immunocytochemical study. Hum Pathol 12: 323–333
Beierwaltes WH, Nishiyama RH, Thompson NW, Coop JE, Kubo A (1982) Survival time and cure in papillary and follicular thyroid carcinoma with distant metastases. J Nucl Med 23: 561–568
Benker G, Reiners C, Krause U, Bamberg M, Reinwein D (1988) Schilddrüsenkarzinome — aktuelle diagnostische und therapeutische Strategien. Internist 24: 564–574
Breslow N, Churchill G, Nesmith B, Thomas PRM, Beckwith BJ, Othersen HB, d’Angio GJ (1986) Clinicopathologic features and prognosis for Wilms tumor patients with metastases at diagnosis. Cancer 58: 2501–2511
Breur K, Cohen P, Schweisguth O, Hart AMM (1978) Irradiation of the lung as an adjuvant therapy in the treatment of osteosarcoma of the limbs. Eur J Cancer 14: 461–474
Brown AP, Fixsen JA, Plowman PN (1987) Local control of Ewing’s sarcoma. An analysis of 67 patients. Br J Radiol 60: 261–268
Bünemann H, Heilmann HP (1984) Tumoren der Atmungsorgane. In: Heilmann HP (Hrsg) Spezielle Strahlentherapie maligner Tumoren. Springer, Berlin Heidelberg New York Tokio (Handbuch medizinische Radiologie 14/5, S 299–451 )
Burges JM, van Glabbecke M, Bussan A et al. (1988) Osteosarcoma of the limbs. Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with che-motherapy and/or prophilactic lung irradiation. Cancer 61: 1024–1031
Crow J, Slavin G, Kreel L (1981) Pulmonary metastasis: A pathologic and radiologic study. Cancer 47: 2595–2602
d’Angio GJ, Breslow N, Beckwith JB et al. (1989) Treatment of Wilms tumor. Results of the 3rd national Wilms tumor study. Cancer 64: 349–360
Didolkar MS, Fanous N, Elias EG, Moore RH (1977) Metastatic carcinomas from occult primary tumours. Ann Surg 186: 625–630
Gatter KC, Alcock C, Heryet A, Mason DY (1985) Clinical importance of analysing malignant tumours of uncertain origin with immunohistochemical techniques. Lancet 11: 1302–1305
Greco FA, Hainsworth JD (1997) Cancer of unknown primary site. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology, 5th edn. Lippincott, Philadelphia, pp 2423–2445
Greco FA, Vaughn WK, Hainsworth JD (1986) Advanced poorly differentiated carcinoma of unknown primary site: Recognition of a treatable syndrome. Ann Intern Med 104: 547–556
Gross NJ (1981) The pathogenesis of radiation induced lung damage. Lung 159: 115–127
Hainsworth JD, Wright EP, Gray GF Jr, Greco FA (1987) Poorly differentiated carcinoma of unknown primary site: Correlation of light microscopic findings with response to cisplatin-based comoination chemotherapy. J Clin Oncol 5: 1275–1280
Hainsworth JD, Wright E, Davis B, Johnson D, Greco FA (1989) Immunoperoxidase staining in the evaluation of poorly differentiated carcinoma of unknown primary site. Proc ASCO (Abstr) 8: 11
Hales SA, Gatter KC, Heryet A, Mason DY (1989) The value of immunocytochemistry in differentiating high-grade lymphoma from other anaplastic tumours: A study of anaplastic tumours from 1940 to 1960. Leuk Lymphoma 1: 59–63
Horning SJ, Carrier EK, Rouse RV (1989) Lymphomas presenting as histologically unclassified neoplasms: Characteristics and response to treatment. J Clin Oncol 7: 1281–1287
Jenkins RDT (1977) Radiation treatment of Ewing’s sarcoma and osteogenetic sarcoma. Can J Surg 20: 530–536
Jenkins RDT, Rider WD, Sonley MJ (1976) Ewing’s sarcoma. Adjuvant total body irradiation, cyclophosphamide ana vincristine. Int J Radiat Oncol Biol Phys 1: 407–413
Jennings FL, Arden A (1962) Development of radiation pneumonitis: time and dosis factors. Arch Pathol 74: 351–358
Jereb B, Issac R, Tournade MF et al. (1985) Survival of patients with metastases from Wilms tumor (SIOP 1, 2, 5). Eur Paediatr Haematol Oncol 2: 71–76
Kreisman H, Wolkove N (1992) Pulmonary toxicity of antineoplastic therapy. Semin Oncol 19: 508–520
Lindeman GJ, Tattersall M (1995) Tumours of unknown primary site. In: Peckham M, Pinedo HM, Veronesi U (eds) Oxford textbook of oncology. Oxford Medical Publ, Oxford New York Tokio, pp 2155–2165
Liotta LA, Kleinerman J, Saiael FM (1976) The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36: 889–893
Manegold C, Stahel R, Mattson K et al. (on behalf of a European multinational study group) (1997) Randomized phase-II-study of Gemcitabine monotherapy vs. cisplatin plus etoposide in patients with locally advanced or metastatic non-small cell lung cancer. Proc ASCO 16: 460 a, 1651
Nystrom JS, Weiner JM (1977) Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 4: 53–58
Perez CA, Tefft M, Nesbit M et al. (1981) Radiation therapy in the multimodal management of Ewing’s-sarcoma of the bone. Report of the IESS. Natl Cancer Inst Monogr 56: 263–271
Rab GT, Ivins JC, Childs DS, Cupps RE, Pritchard DJ (1976) Elective whole lung irradiation in the treatment of osteogenic sarcoma. Cancer 38: 939–942
Schildt RA, Kennedv PS, Chen TT (1983) Management of patients with metastatic adenocarcinoma of unknown origin: A Southwest Oncology Group study. Cancer Treat Rep 67: 77–79
Schölten ET, Kreel L (1977) Distribution of lung metastases in the axial plane. Radiol Clin N Am 46: 248–261
Stea B, Kinsella TJ, Triche TJ, Horvath K, Glatstein E, Miser JS (1987) Treatment of pelvic sarcoma in adolescents and young adults with intensive combined modality therapy. Int J Radiat Oncol Biol Phys 13: 1797–1805
Twohig K, Matthay R (1990) Pulmonary effects of cytotoxic agents other than bleomycin. Clin Chest Med 11: 31–42
Viettie TJ, Geban EA, Nesbit M et al. (1981) Multimodal therapy in metastatic Ewing’s-sarcoma of the bone. Report of the less. Natl Cancer Inst Monogr 56: 279–284
Wara WM, Philipps TL, Margolis LW (1973) Radiation pneumonitis. A new approach to the derivation of time dose factors. Cancer 32: 547–552
Willis RA (1973) Secondary tumors of the lung. The spread of tumors in the human body. Butter worth, London, pp 167–174
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Manegold, C., Flentje, M. (1998). Nichtoperative Behandlung von Lungenmetastasen solider Tumoren. In: Drings, P., Vogt-Moykopf, I. (eds) Thoraxtumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72041-3_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-72041-3_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72042-0
Online ISBN: 978-3-642-72041-3
eBook Packages: Springer Book Archive